The effect of bronchodilators administered via aerochamber or a nebulizer on inspiratory lung function parameters

1991, Aerosol consensus statement: Consensus Conference on Aerosol Delivery, Chest, 100, 1106, 10.1378/chest.100.4.1106 Mestitz, 1989, Comparison of beta-adrenergic agents delivered by nebulizer vs metered dose inhaler terbutaline in chronic airflow obstruction, Chest, 96, 1237, 10.1378/chest.96.6.1237 Gunawardena, 1986, A comparison of metered dose inhalers with nebulizers for the delivery of ipratropium bromide in domiciliary practice, Br J Dis Chest, 80, 170, 10.1016/0007-0971(86)90038-0 Jenkins, 1987, Comparison or domiciliary nebulized salbutamol and salbutamol from a metered dose inhaler in stable chronic airflow limitation, Chest, 91, 804, 10.1378/chest.91.6.804 Dolovich, 2005, Device selection and outcomes of aerosol therapy: evidence-based guidelines, Chest, 127, 335, 10.1378/chest.127.1.335 Idris, 1993, Emergency department treatment of severe asthma. Metered-dose inhaler plus holding chamber is equivalent in effectiveness to nebulizer, Chest, 103, 665, 10.1378/chest.103.3.665 Turner, 1997, Bronchodilator delivery in acute airflow obstruction: a meta-analysis, Arch Intern Med, 157, 1736, 10.1001/archinte.1997.00440360162018 O'Driscoll, 1992, A long-term prospective assessment of home nebulizer treatment, Respir Med, 86, 317, 10.1016/S0954-6111(06)80031-4 Wilson, 1980, Domiciliary nebulized salbutamol solution in severe chronic airway obstruction, Thorax, 35, 873, 10.1136/thx.35.11.873 Morrison, 1992, Assessing physiological benefit from domiciliary nebulized bronchodilators in severe airflow limitation, Eur Respir J, 5, 424, 10.1183/09031936.93.05040424 Goldman, 1992, Simplifying the assessment of patients with chronic airflow limitation for home nebulizer therapy, Respir Med, 86, 33, 10.1016/S0954-6111(06)80145-9 Noseda, 1993, How do patients with either asthma or COPD perceive acute bronchodilation?, Eur Respir J, 6, 6636, 10.1183/09031936.93.06050636 Noseda, 1992, Perceived effect on shortness of breath of an acute inhalation of saline or terbutaline: variability and sensitivity of a visual analogue scale in patients with asthma or COPD, Eur Respir J, 5, 1043, 10.1183/09031936.93.05091043 Taube, 2000, Factor analysis of changes in dyspnea and lung function parameters after bronchodilation in chronic obstructive pulmonary disease, Am J Respir Crit Care Med, 162, 216, 10.1164/ajrccm.162.1.9909054 Puente-Maestu, 2006, Hyperinflation and its management in COPD, Int J Chron Obstruct Pulmon Dis, 1, 381 Newton, 2002, Response of lung volumes to inhaled salbutamol in a large population of patients with severe hyperinflation, Chest, 121, 1042, 10.1378/chest.121.4.1042 Tantucci, 1998, Effect of salbutamol on dynamic hyperinflation in chronic obstructive pulmonary disease patients, Eur Respir J, 12, 799, 10.1183/09031936.98.12040799 Taube, 2003, Reproducibility of forced inspiratory and expiratory volumes after bronchodilation in patients with COPD or asthma, Respir Med, 97, 568, 10.1053/rmed.2001.1411 Taube, 2001, Airway response to inhaled hypertonic saline in patients with moderate to severe chronic obstructive pulmonary disease, Am J Respir Crit Care Med, 164, 1810, 10.1164/ajrccm.164.10.2104024 Taube, 2011, Use of a portable device to record maximum inspiratory flow in relation to dyspnea in patients with COPD, Respir Med, 105, 316, 10.1016/j.rmed.2010.11.017 Calverley, 2006, Dynamic hyperinflation: is it worth measuring?, Proc Am Thorac Soc, 3, 239, 10.1513/pats.200508-084SF O'Donnell, 1998, Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease, Am J Respir Crit Care Med, 158, 1557, 10.1164/ajrccm.158.5.9804004 O'Donnell, 2001, Evaluation of bronchodilator responses in patients with irreversible emphysema, Eur Respir J, 18, 914, 10.1183/09031936.01.00216501 O'Donnell, 2004, Effects of tiotropium on lung hyperinflation, dyspnea and exercise tolerance in COPD, Eur Respir J, 23, 832, 10.1183/09031936.04.00116004 Ramlal, 2010, Reversibility of inspiratory lung function parameters after short-term bronchodilators in COPD, Respir Physiolo Neurobiol, 173, 58, 10.1016/j.resp.2010.06.007 Pauwels, 2001, Global strategy for the diagnosis, management and prevention of chronic obstructive lung disease (GOLD) workshop summary, Am J Respir Crit Care Med, 163, 1256, 10.1164/ajrccm.163.5.2101039 American Thoracic Society, 1995, Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease, Am J Respir Crit Care Med, 152, S72 Celli, 2004, Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper, Eur Respir J, 23, 932, 10.1183/09031936.04.00014304 Quanjer, 1983, Summary of recommendations, Bull Eur Physiopathol Respir, 19, 7 Roca, 1998, References values for forced spirometry. Group of the European Community Respiratory Health Survey, Eur Respir J, 11, 1354, 10.1183/09031936.98.11061354 Visser, 2008, Recommendations for the measurement of FIV1 values in chronic obstructive pulmonary disease, Respiration, 76, 46, 10.1159/000111603 Visser, 2010, Random variation of inspiratory lung function parameters in patients with COPD: a diagnostic accuracy study, BMC Pulm Med, 10, 28, 10.1186/1471-2466-10-28 Fink, 2010, Humidity and aerosol therapy, 91 Geller, 2005, Comparing clinical features of the nebulizer, metered-dose inhaler, and dry powder inhaler, Respir Care, 50, 1313 O'Callaghan, 1993, Improvement in sodium cromoglycate delivery from a spacer device by use of an antistatic lining, immediate inhalation and avoiding multiple actuations of drug, Thorax, 48, 603, 10.1136/thx.48.6.603 Newman, 1981, Deposition of pressurized aerosols in the human respiratory tract, Thorax, 36, 52, 10.1136/thx.36.1.52 Zainudin, 1990, Comparison of bronchodilator responses and deposition patterns of salbutamol inhaled from pressurized metered dose inhaler, as dry powder inhaler and as a nebulized solution, Thorax, 45, 469, 10.1136/thx.45.6.469 Boni, 2002, Volume effect and exertional dyspnea after bronchodilator in COPD patients with and without expiratory flow limitation at rest, Thorax, 57, 528, 10.1136/thorax.57.6.528 Pellegrino, 1997, Lung hyperinflation and flow limitation in chronic airway obstruction, Eur Respir J, 10, 543, 10.1183/09031936.97.10030543 Di Marco, 2003, Effect of inhaled bronchodilators on inspiratory capacity and dyspnea at rest in COPD, Eur Respir J, 21, 86, 10.1183/09031936.03.00020102